Independent Research set a €53.00 ($61.63) price objective on Fresenius SE & Co KGaA (FRA:FRE) in a report issued on Friday, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

A number of other research firms have also recently commented on FRE. Kepler Capital Markets set a €62.00 ($72.09) price target on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Monday, March 11th. Goldman Sachs Group set a €52.00 ($60.47) price target on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Thursday, May 2nd. Berenberg Bank set a €70.95 ($82.50) price target on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Wednesday, April 24th. Jefferies Financial Group set a €47.00 ($54.65) price target on Fresenius SE & Co KGaA and gave the stock a neutral rating in a report on Friday, January 11th. Finally, Warburg Research set a €65.00 ($75.58) price objective on Fresenius SE & Co KGaA and gave the stock a buy rating in a report on Thursday, May 2nd. Ten investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company has a consensus rating of Buy and an average target price of €59.29 ($68.94).

Fresenius SE & Co KGaA stock opened at €49.98 ($58.11) on Friday. Fresenius SE & Co KGaA has a 52 week low of €60.16 ($69.95) and a 52 week high of €80.00 ($93.02).

About Fresenius SE & Co KGaA

Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.

Further Reading: How to read a candlestick chart

Analyst Recommendations for Fresenius SE & Co KGaA (FRA:FRE)

Receive News & Ratings for Fresenius SE & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.